Telehealth has limitations for patients with conditions like severe gastroparesis, pancreatitis history, or complex endocrine disorders
Per KFF 2025, 43% of firms with 5,000-plus employees cover weight-loss GLP-1s (up from 28%), but only 30% of firms with 1,000 to 4,999 employees and 16% of firms with 200 to 999
Slows intestinal motility
Titration, Monitoring & Protocol Adjustment Both semaglutide and tirzepatide require slow titration to minimize GI side effects and allow your body to adapt
I saw on Threads that it helps you lose weight faster than anything else
The primary sources for this report include: Recalls (Enforcement Reports Database) The Food and Drug Administration (FDA) categorizes product recalls in its Enforcement Report database based on the level of health risk, labeling them as Class I, II, III, or not yet classified. While the database includes drugs, food, cosmetics, medical devices, biologics, tobacco, and veterinary products, this report only covers selected drug recalls